CVS HEALTH closed at $93.47 on Oct 23, down 1.07%, 15.5% below its 52-week closing high. Volume of 4.6M shares was 0.49× its 20-day average (below normal).
Split-adjusted performance: +9.9% over one month, +19.9% over six months, +14.0% over one year.
In the quarter ended Jun 30, 2026, revenue was $105.45B, up 7.1% from a year earlier, with a net margin of 2.8%.
Short interest was 16.5M shares at the Sep 30 settlement, up 2.1% from the prior report (1.3% of float, 1.7 days to cover).